Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Misato Hashizume »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Misako Higashida-Konishi < Misato Hashizume < Misato Jono  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000081 (2008) Yasushi Uchiyama [Japon] ; Keigo Yorozu ; Misato Hashizume ; Yoichiro Moriya ; Masahiko MiharaTocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis.
000098 (2009) Misato Hashizume [Japon] ; Masahiko MiharaInfluence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
000151 (2010) Miho Suzuki [Japon] ; Misato Hashizume ; Hiroto Yoshida ; Masahiko MiharaAnti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule.
000165 (2010) Misato Hashizume [Japon] ; Yasushi Uchiyama ; Naoto Horai ; Naohisa Tomosugi ; Masahiko MiharaTocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production.
000489 (2011) Misato Hashizume [Japon] ; Masahiko MiharaThe roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.
000890 (2014) Keisuke Tanaka [Japon] ; Misato Hashizume ; Masahiko Mihara ; Hiroto Yoshida ; Miho Suzuki ; Yoshihiro MatsumotoAnti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model.
000975 (2014) Naoshi Nishina [Japon] ; Jun Kikuchi ; Misato Hashizume ; Keiko Yoshimoto ; Hideto Kameda ; Tsutomu TakeuchiBaseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy.
000B74 (2015) Misato Hashizume [Japon] ; Seng-Lai Tan ; Junichi Takano ; Kazunori Ohsawa ; Ikuo Hasada ; Akira Hanasaki ; Ichiro Ito ; Masahiko Mihara ; Keiichiro NishidaTocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights.
000D12 (2015) Jun Kikuchi [Japon] ; Misato Hashizume [Japon] ; Yuko Kaneko [Japon] ; Keiko Yoshimoto [Japon] ; Naoshi Nishina [Japon] ; Tsutomu Takeuchi [Japon]Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
001019 (2015) Keisuke Izumi [Japon] ; Yuko Kaneko [Japon] ; Misato Hashizume [Japon] ; Keiko Yoshimoto [Japon] ; Tsutomu Takeuchi [Japon]Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).
001111 (2016) Keisuke Izumi ; Yuko Kaneko ; Misato Hashizume ; Keiko Yoshimoto ; Tsutomu TakeuchiCorrection: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).
001A90 (2018) Alison O'Mahony [États-Unis] ; Markus R. John [Suisse] ; Hannah Cho [États-Unis] ; Misato Hashizume [Suisse] ; Ernest H. Choy [Royaume-Uni]Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate.
002C46 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Misato Hashizume" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Misato Hashizume" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Misato Hashizume
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021